JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoenemann, C. W.
Right arrow Articles by Van Aken, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoenemann, C. W.
Right arrow Articles by Van Aken, H.
Related Collections
Right arrow Monitoring (Non-cardiac)
Right arrow Pharmacology

Anesth Analg 2003;96:165-167
© 2003 International Anesthesia Research Society

ANESTHETIC PHARMACOLOGY

Delayed Onset of Malignant Hyperthermia in Desflurane Anesthesia

Christian W. Hoenemann, MD*,{dagger}, Tobias B. Halene-Holtgraeve*, Michael Booke, MD, PhD*, Frank Hinder, MD, PhD*, Fritz Daudel, MD*, Alexander Reich, MD*, and Hugo Van Aken, MD, PhD*

*Department of Anesthesiology and Critical CareUniversitätsklinikum Münster, Münster; and {dagger}Department of Anesthesiology and Critical CareMarienhospital Vechta, Vechta, Germany

Address correspondence and reprint requests to C. W. Hoenemann, Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Münster, Albert Schweitzer Straße 33, 48129 Münster, Germany. Address e-mail to hoenemann@ anit.uni-muester.de.

IMPLICATIONS: Animal-experimental studies demonstrate desflurane’s trigger effect for malignant hyperthermia (MH). In contrast to other anesthetics, the time interval from exposure to the occurrence of symptoms is much longer with desflurane. This case report focuses on MH induced by desflurane alone.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
I. Kwetny and B. T. Finucane
Negative arterial to end-tidal carbon dioxide gradient: an additional sign of malignant hyperthermia during desflurane anesthesia.
Anesth. Analg., March 1, 2006; 102(3): 815 - 817.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. A. Uskova, B. P. Matusic, and B. W. Brandom
Desflurane, Malignant Hyperthermia, and Release of Compartment Syndrome
Anesth. Analg., May 1, 2005; 100(5): 1357 - 1360.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. J. Papadimos, M. Almasri, J. C. Padgett, and J. E. Rush
A Suspected Case of Delayed Onset Malignant Hyperthermia with Desflurane Anesthesia
Anesth. Analg., February 1, 2004; 98(2): 548 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
F. Wappler, M. Fiege, and C. Honemann
Is Desflurane a "Weak" Trigger of Malignant Hyperthermia? * Response
Anesth. Analg., July 1, 2003; 97(1): 295 - 295.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.